Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qinghe Zeng

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2024
Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant ChemotherapyElisa Yaniz-Galende, Qinghe Zeng, Juan F Bejar-Grau, et al.
Hepatology (Baltimore, Md.)|April 8, 2026
Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with BCLC a hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial)Pierre Nahon, Marianne Ziol, Long Pan, et al.
The Lancet. Oncology|November 11, 2023
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective studyQinghe Zeng, Christophe Klein, Stefano Caruso, et al.
Nature Communications|December 13, 2023
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinomaJulien Calderaro, Narmin Ghaffari Laleh, Qinghe Zeng, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2024
Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant ChemotherapyElisa Yaniz-Galende, Qinghe Zeng, Juan F Bejar-Grau, et al.
Hepatology (Baltimore, Md.)|April 8, 2026
Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with BCLC a hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial)Pierre Nahon, Marianne Ziol, Long Pan, et al.
The Lancet. Oncology|November 11, 2023
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective studyQinghe Zeng, Christophe Klein, Stefano Caruso, et al.
Nature Communications|December 13, 2023
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinomaJulien Calderaro, Narmin Ghaffari Laleh, Qinghe Zeng, et al.
Pageof 5